Jump to: navigation, search

Avatrombopag (Doptelet)

1 byte added, 22:46, 1 December 2016
Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm"
border-style:solid;">Randomized Phase II, >20 per arm</span>
# Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. [ link to original article] [http PubMed]
==Also known as==

Navigation menu